{"nct_id":"NCT01673854","title":"Phase II Safety Study of Vemurafenib Followed by Ipilimumab in Subjects With V600 BRAF Mutated Advanced Melanoma","status":"COMPLETED","status_verified_date":"2018-06","start_date":"2012-09-13","start_date_type":"ACTUAL","primary_completion_date":"2014-07-25","primary_completion_date_type":"ACTUAL","completion_date":"2015-05-12","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["BMY"]}